[U.S.] Decentralized Trials: How to Develop a Flexible Supply Chain Strategy
Today’s decentralized and virtual trials require a shift to Direct-to-Patient (DTP) distribution to keep trials moving forward. Join this webinar to explore opportunities to optimize a supply chain strategy that accommodates both Direct-to-Site and Direct-to-Patient services utilizing a global Good Manufacturing Practices (GMP) depot network along with DTP and Direct-from-Patient (DFP) services.
DTP services improve patient retention and engagement. Storing clinical drug products and supplies geographically closer to patients or sites can help mitigate the risk of products becoming damaged in transport, as well as avoiding trial disruptions and minimizing delays due to import regulations.
Join Marken’s experts as we explore opportunities to optimize your supply chain strategy to facilitate both Direct-to-Site and Direct-to-Patient services utilizing a global GMP depot network. Learn the keys to successfully navigating critical paths, including project management, set-up processes, and risk assessment to drive your trial forward.
Reserve your free spot.Click here to learn more or register